In this episode of SurgOnc Today, the SSO HPB disease site working group reviews strategies for implementation of histothripsy ablation in the management of liver primary and secondary malignancies, including a discussion of the evidence supporting it and support from the IDEAL framework for the adoption of surgical innovations into clinical practice. To do so, Drs. Miral Sadaria Grandhi and Zhi Ven Fong, members of the HPB disease site working group, are joined by Drs. Hop Tran Cao, Brock Hewitt, and Jeffrey Barkun.

Drs. Kavita Vakharia, surgical oncologist from City of Hope, Dr Sara Bateni, surgical oncologist at University of Alabama at Birmingham, Dr Nikhil Khushalanai, medical oncologist at the H. Lee Moffitt Cancer Center and James Jakub, surgical oncologist at the Mayo Clinic, Florida, discuss their current practice regarding multidisciplinary management of melanoma with a focus on the role of adjuvant systemic therapy for stages IIB, IIC and IIIA disease.

In this new episode of Speaking of SurgOnc, Dr. Rick Greene discusses with Dr. Helen Johnson and Dr. Katrina Mitchell the management of patients with breast cancer diagnosed during pregnancy or lactation, and guidance provided regarding surgery, radiation, and systemic therapy, as reported in the article, "Oncolactation for Patients with Breast Cancer: Executive Summary from the American Society of Breast Surgeons."

In this episode of SurgOnc Today, Dr. Doreen Agnese, Dr. Anna C Beck and Dr. Andrea Abbott will discuss different delivery models for genetic testing, including traditional genetic testing and point of care testing. We will discuss potential pitfalls associated with point of care testing and interpretation of results.

On this episode of SurgOnc today, Dr. Rosalinda Alvarado and Dr. George Molina moderate a discussion on how to improve the recruitment of Hispanic/Latino patients into clinical trials. Joining the conversation are Jeanette Gonzalez from the University of Illinois Cancer Center and Alas-Wings, Dr. Narjust Florez from Dana-Farber Cancer Institute and Harvard Medical School, and Dr. Kennedy Timothy from MedStar Health and Georgetown University.

On this episode of SurgOnc Today, Mr. Myles Smith, Dr. Hari Deshpande, Dr. Alexandra Istl, & Dr. Danielle Cunningham will discuss the treatment of two rare subtypes of sarcoma, highlighting the differences and challenges of diagnosis and treatment. Both types may represent potentially curable cancers and should always be managed, if possible, by a multidisciplinary tertiary center.

In this episode of SurgOnc Today, SSO Peritoneal Surface Malignancy Disease Site Working Group members Dr. Alissa Greenbaum and Dr. Omar Llaguna moderate a discussion with Dr. Maheswari Senthil of UC Irvine and Dr. Richard Alexander of the Rutgers Cancer Institute of New Jersey to dive deep into the history of the development of regional therapies such as HIPEC and PIPAC in the United States. The expert discussants answer tough questions regarding the ethical considerations of modern clinical trials and the implementation of experimental therapies into practice.

In this episode, Dr. Russell Berman sits down with Dr. Sandra Wong, Dean of Emory University School of Medicine, and Dr. David Linehan, Dean of University of Rochester School of Medicine and Dentistry. Together, they share what it means to step beyond the operating room and into the role of shaping the future of medical education. From leading surgical oncology programs to leading entire medical schools, Drs. Wong and Linehan discuss their journeys, the challenges of balancing clinical, research, and administrative responsibilities, and how surgical oncologists are uniquely positioned to guide the next generation of physicians.

In this new episode of Speaking of SurgOnc, Dr. Rick Greene discusses with Dr. Faina Nakhlis the upgrade rate to ductal carcinoma in situ or invasive cancer following excision for patients diagnosed with flat epithelial atypia on core biopsy, as reported in the article, "Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or Ductal Carcinoma In Situ in Patients Diagnosed with Flat Epithelial Atypia by Core Needle Biopsy (TBCRC 034)."

In this bite-sized episode of SurgOnc Today, Drs. Zhi Ven Fong and Adriana Gamboa discuss palliative techniques for the management of gastric outlet obstruction in pancreatic cancer. Stay tuned for Part 2!